Weeks after closing a deal to buy Jounce Therapeutics, Concentra Biosciences is rebounding to pick up another struggling biotech, this time COVID-19-focused Atea Pharmaceuticals.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,